Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation
FJA Penning-van Beest, E van Meegen… - Thrombosis and …, 2001 - thieme-connect.com
The risk of hemorrhage when using coumarin anticoagulants sharply increases when the
International Normalised Ratio (INR) is≥ 6.0. We performed a prospective cohort study with …
International Normalised Ratio (INR) is≥ 6.0. We performed a prospective cohort study with …
Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
D Barcellona, ML Vannini, L Fenu… - Thrombosis and …, 1998 - thieme-connect.com
Warfarin is employed more frequently than acenocoumarol because of its longer half-life (36
h), theoretically providing more stable anticoagulation, and avoiding factor VII fluctuations …
h), theoretically providing more stable anticoagulation, and avoiding factor VII fluctuations …
Comparison of control and stability of oral anticoagulant therapy using acenocoumarol versus phenprocoumon
SD Fihn, AAP Gadisseur, E Pasterkamp… - Thrombosis and …, 2003 - thieme-connect.com
Variability in the control of oral anticoagulant therapy has been associated with a
heightened risk of complications. We compared control of anticoagulation between two …
heightened risk of complications. We compared control of anticoagulation between two …
Therapeutic quality control of oral anticoagulant therapy comparing the short‐acting acenocoumarol and the long‐acting phenprocoumon
APA Gadisseur, FJM Van Der Meer… - British journal of …, 2002 - Wiley Online Library
To investigate whether the different pharmacokinetics of acenocoumarol (t1/2= 11 h) and
phenprocoumon (t1/2= 140 h) result in a different quality of anticoagulation, we studied …
phenprocoumon (t1/2= 140 h) result in a different quality of anticoagulation, we studied …
The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon
Y van Leeuwen, FR Rosendaal, FJM van der Meer - Thrombosis research, 2008 - Elsevier
INTRODUCTION: Vitamin K antagonists of the coumarin type are widely used oral
anticoagulants. OBJECTIVE: We developed a transition algorithm for the maintenance …
anticoagulants. OBJECTIVE: We developed a transition algorithm for the maintenance …
[HTML][HTML] Warfarin and phenprocoumon: experience of an outpatient anticoagulation clinic
TLL Leiria, L Pellanda, MH Miglioranza… - Arquivos brasileiros de …, 2010 - SciELO Brasil
FUNDAMENTO: Os anticoagulantes orais são amplamente utilizados na cardiologia.
Contudo, uma avaliação sobre o seu uso na prática clínica ainda é necessária. OBJETIVOS …
Contudo, uma avaliação sobre o seu uso na prática clínica ainda é necessária. OBJETIVOS …
[HTML][HTML] Varfarina e femprocumona: experiência de um ambulatório de anticoagulação
TLL Leiria, L Pellanda, MH Miglioranza… - Arquivos Brasileiros …, 2010 - SciELO Brasil
FUNDAMENTO: Os anticoagulantes orais são amplamente utilizados na cardiologia.
Contudo, uma avaliação sobre o seu uso na prática clínica ainda é necessária. OBJETIVOS …
Contudo, uma avaliação sobre o seu uso na prática clínica ainda é necessária. OBJETIVOS …
Quality of oral anticoagulant therapy in patients who perform self management: warfarin versus phenprocoumon
CF Jensen, TD Christensen, M Maegaard… - Journal of thrombosis …, 2009 - Springer
Background The quality of oral anticoagulant therapy may be related to which type of
coumarin is used. The aim was to investigate whether phenprocoumon or warfarin provide …
coumarin is used. The aim was to investigate whether phenprocoumon or warfarin provide …
[HTML][HTML] Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study
JHA van Miert, NJGM Veeger, AJ ten Cate-Hoek… - PLoS …, 2020 - journals.plos.org
Background Treatment with vitamin K antagonists (VKA) requires a high proportion of time in
the therapeutic range (TTR) and a low international normalised ratio (INR) variability to be …
the therapeutic range (TTR) and a low international normalised ratio (INR) variability to be …
Comparative study of the clinical effect of acenocoumarol (Sintrom®) and phenprocoumon (Marcoumar®) in myocardial infarction and angina pectoris
N Fekkes, H De Jonge, JJ Veltkamp… - Acta Medica …, 1971 - Wiley Online Library
A controlled clinical trial was performed in more than 250 patients with myocardial infarction
or angina pectoris to determine whether any difference in clinical effect could be observed …
or angina pectoris to determine whether any difference in clinical effect could be observed …